For the CX3CR1 T280M and V249I polymorphisms, the heterogeneity can partly be explained by the ethnicity (Caucasians and Asian), subtype of atherosclerotic diseases (CAD, CAA, and ICVD), and source of control (hospital-based and population-based). This evidence concerns the gene CX3CR1 and coronary artery disorder.